Valuation: Incyte Corporation

Market Cap 25.27B 22.03B 20.75B 18.9B 35.43B 2,421B 35.47B 248B 95.77B 1,233B 94.91B 92.81B 3,979B P/E 2026 *
55.6x
P/E 2027 * 17.2x
Enterprise Value 21.04B 18.34B 17.28B 15.73B 29.5B 2,015B 29.53B 207B 79.74B 1,027B 79.02B 77.27B 3,313B EV / Sales 2026 *
3.54x
EV / Sales 2027 * 3.08x
Free-Float
98.14%
Yield 2026 *
-
Yield 2027 * -
1 day+1.18%
1 week+3.63%
Current month+2.38%
1 month-1.43%
3 months+21.70%
6 months+39.47%
Current year+27.73%
1 week 121.48
Extreme 121.48
128.72
1 month 119.97
Extreme 119.97
130.8
Current year 89.25
Extreme 89.25
132.6
1 year 81.09
Extreme 81.09
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
15/9/26 Exercice

Chairperson

69,654 0.0344%
25/8/26 Tax

EVP, Human Resources

-504 0.0002%
19/8/26 Sell

Chairperson

-10,801 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
+1.18%+3.63%+48.89%+117.13% 25.27B
+0.45%+3.24%+34.16%-3.11% 79.7B
+7.94%+27.50%+590.14%+83.32% 69.04B
+1.36%+5.33%-8.90%-29.50% 60.82B
-0.78%-2.04%-11.65%+27.42% 47.16B
-0.14%+0.81%+2.47%+157.67% 46.38B
+2.51%+3.68%+59.33%-13.02% 32.37B
+0.68%+6.45%+12.00%+172.03% 22.72B
+1.24%+2.00%+59.23%+104.00% 15.7B
+3.38%-0.02%+32.66%+150.73% 13.02B
Average +1.76%+2.13%+81.83%+76.67% 41.22B
Weighted average by Cap. +1.96%+3.83%+114.70%+54.24%

Financials

2026 *2027 *
Net sales 5.94B 5.18B 4.88B 4.44B 8.33B 569B 8.34B 58.44B 22.52B 290B 22.32B 21.83B 936B 6.27B 5.46B 5.14B 4.69B 8.78B 600B 8.8B 61.61B 23.75B 306B 23.53B 23.01B 987B
Net income 466M 406M 383M 348M 653M 44.63B 654M 4.58B 1.77B 22.73B 1.75B 1.71B 73.36B 1.5B 1.3B 1.23B 1.12B 2.1B 143B 2.1B 14.71B 5.67B 73B 5.62B 5.49B 236B
Net Debt -4.23B -3.69B -3.47B -3.16B -5.93B -405B -5.94B -41.6B -16.03B -206B -15.89B -15.54B -666B -5.99B -5.22B -4.92B -4.48B -8.4B -574B -8.41B -58.92B -22.71B -292B -22.5B -22.01B -943B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
23/09/26 USD 126.46 +1.45% 218,210
21/09/26 USD 124.65 -0.53% 1,270,531
18/09/26 USD 125.31 -1.81% 3,700,438
17/09/26 USD 127.62 +2.30% 1,468,843
16/09/26 USD 124.75 +2.47% 1,347,302
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
124.65USD
Average target price
127.74USD
Spread / Average Target
+2.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!